If you think your medicine may be contributing to overheating, it’s very important you keep taking your medicine. Discuss your symptoms with your pharmacist or doctor.
Academic rigor, journalistic flair
Articles on Pharmaceuticals
Displaying 1 - 20 of 190 articles
Drinking alcohol with some medicine means they may not work so well. With others, you risk a life-threatening overdose.
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
About half the population of people taking regular medicines don’t take them as prescribed. Here are some tips to help you remember.
Despite technological advancements, many challenges remain in getting a drug from lab to pharmacy shelf. Reframing what is a “medicine” could expand treatment options for researchers and patients.
Sometimes, it’s best to take your medicine sitting up. Other times, lying down is safer. Here’s what we know so far.
Each of these five drugs have brought some incredible benefits. But they’ve usually also come with a legacy of complications.
As antibiotics lose their power to treat some forms of TB, interest in the antibacterial powers of curdlan is rising.
Believe it or not, medication names are intended to be easy to remember and descriptive of the function they serve in the body.
From tablets and patches to ointments and infusions, the best way to deliver a drug is the one that gets the right amount to the right place.
As long as industrial policies in Nigeria are introduced only as a crisis response, import restrictions will continue to be their focus.
About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
An infectious disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
While technological advancements have quickened the drug discovery process, some chemical compounds remain a common thorn in a researcher’s side.
Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.
Changes in the latest federal budget will mostly affect people who need multiple medicines throughout the year, perhaps for chronic disease. But there are other ways to reduce drug costs.
It’s easy to blame COVID. But Australia has suffered medicine shortages for years. The pandemic has only highlighted the problem. Here’s what we could do to better avoid shortages in the first place.
Drug development is a long and costly process that often ends in failure. Improving the way potential drug candidates are optimized could help boost success rates.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
We’ve made a few mistakes in the past two years, when it comes to developing COVID drugs. Some were obvious and could have easily been avoided.
Top contributors
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Pharmacist and PhD Candidate, University of Sydney
-
Assistant Professor, Bond University
-
HERA Program Director - Health Workforce Optimisation Centre for the Business & Economics of Health, The University of Queensland
-
PhD Candidate, Swinburne University of Technology
-
Associate Lecturer Pharmacy Practice, University of Sydney
-
ARC Future Fellow, Australian National University
-
Associate Professor, School of Law, University of Canberra
-
Professor and Personal Chair, Swansea University
-
Professor of Bioethics, Macquarie University
-
Senior Staff Specialist, Alice Springs Hospital. Purple House Medical Advisor. Honorary ANU., Australian National University
-
Stephen Duckett is a Friend of The Conversation.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice, The University of Melbourne
-
Professor in Economics, University of Bath
